Evolus Short Term Coverage Ratios from 2010 to 2025

EOLS Stock  USD 14.32  0.36  2.58%   
Evolus Short Term Coverage Ratios yearly trend continues to be comparatively stable with very little volatility. Short Term Coverage Ratios will likely drop to -8.03 in 2025. From the period from 2010 to 2025, Evolus Short Term Coverage Ratios quarterly data regression had r-value of (0.22) and coefficient of variation of (191.39). View All Fundamentals
 
Short Term Coverage Ratios  
First Reported
2010-12-31
Previous Quarter
(7.64)
Current Value
(8.03)
Quarterly Volatility
25.93145459
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Evolus financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Evolus' main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Interest Expense of 16.7 M or Selling General Administrative of 190.1 M, as well as many indicators such as Price To Sales Ratio of 4.6, Dividend Yield of 0.0 or Days Sales Outstanding of 74.33. Evolus financial statements analysis is a perfect complement when working with Evolus Valuation or Volatility modules.
  
Check out the analysis of Evolus Correlation against competitors.

Latest Evolus' Short Term Coverage Ratios Growth Pattern

Below is the plot of the Short Term Coverage Ratios of Evolus Inc over the last few years. It is Evolus' Short Term Coverage Ratios historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Evolus' overall financial position and show how it may be relating to other accounts over time.
Short Term Coverage Ratios10 Years Trend
Pretty Stable
   Short Term Coverage Ratios   
       Timeline  

Evolus Short Term Coverage Ratios Regression Statistics

Arithmetic Mean(13.55)
Geometric Mean2.39
Coefficient Of Variation(191.39)
Mean Deviation17.67
Median(0.79)
Standard Deviation25.93
Sample Variance672.44
Range77.7575
R-Value(0.22)
Mean Square Error686.47
R-Squared0.05
Significance0.42
Slope(1.18)
Total Sum of Squares10,087

Evolus Short Term Coverage Ratios History

2025 -8.03
2024 -7.64
2022 -6.65
2021 -26.39
2020 -0.78
2018 -77.82
2017 -0.0617

About Evolus Financial Statements

Evolus shareholders use historical fundamental indicators, such as Short Term Coverage Ratios, to determine how well the company is positioned to perform in the future. Although Evolus investors may analyze each financial statement separately, they are all interrelated. The changes in Evolus' assets and liabilities, for example, are also reflected in the revenues and expenses on on Evolus' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Short Term Coverage Ratios(7.64)(8.03)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Evolus Stock Analysis

When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.